Oncolytics Biotech
ONCY
#9204
Rank
โ‚น9.88 B
Marketcap
โ‚น91.85
Share price
3.80%
Change (1 day)
26.31%
Change (1 year)

Earnings for Oncolytics Biotech (ONCY)

Earnings in 2025 (TTM): -โ‚น2.17 Billion

According to Oncolytics Biotech 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚น2.32 Billion a decrease over its 2023 earnings that were of -โ‚น2.3 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oncolytics Biotech from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น2.17 Billion-6.53%
2024 -โ‚น2.32 Billion1.01%
2023 -โ‚น2.3 Billion23.39%
2022 -โ‚น1.86 Billion-1.98%
2021 -โ‚น1.9 Billion9.1%
2020 -โ‚น1.74 Billion22.64%
2019 -โ‚น1.42 Billion22.78%
2018 -โ‚น1.16 Billion4.1%
2017 -โ‚น1.11 Billion4.87%
2016 -โ‚น1.06 Billion8.75%
2015 -โ‚น0.98 Billion-37.06%
2014 -โ‚น1.55 Billion-26.2%
2013 -โ‚น2.1 Billion-37.39%
2012 -โ‚น3.34 Billion28.8%
2011 -โ‚น2.6 Billion46.02%
2010 -โ‚น1.78 Billion35.64%
2009 -โ‚น1.31 Billion-14.2%
2008 -โ‚น1.53 Billion-0.52%
2007 -โ‚น1.54 Billion24.6%
2006 -โ‚น1.24 Billion45.34%
2005 -โ‚น0.85 Billion-11.8%
2004 -โ‚น0.96 Billion115.36%
2003 -โ‚น0.45 Billion13.86%
2002 -โ‚น0.4 Billion-5.45%
2001 -โ‚น0.42 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Aeterna Zentaris
AEZS
-โ‚น0.5 Billion-77.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.046 T-90,559.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น730.50 B-32,390.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น161.14 B-7,223.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
-โ‚น2.65 Billion 16.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
-โ‚น69.56 Billion 2,974.61%๐Ÿ‡บ๐Ÿ‡ธ USA